CPT 0323U: Metagenomic NGS Assay for CSF Infectious Disease Diagnostics

CPT code 0323U designates a proprietary metagenomic next-generation sequencing (NGS) assay developed and performed by Johns Hopkins Medical Microbiology Laboratory to detect pathogenic organisms in cerebrospinal fluid (CSF) for patients with central nervous system infections of unknown origin. As a PLA code, it is specific to a single laboratory test and manufacturer, signaling a targeted billing pathway for a high-complexity diagnostic service. Nationally, such specialized NGS assays are increasingly important for diagnosing rare, unexpected, or difficult-to-culture infections where conventional testing is inconclusive.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage and contracting implications for proprietary laboratory codes, typical sites of service and clinical context for CSF NGS testing, and the types of benchmarks and policy updates that payers and health systems monitor for PLA codes. The publication will also summarize clinical scenarios where the test is used, operational considerations for laboratory and hospital billing lines, and payer-related documentation and coding practice notes. Data not available in the input are clearly identified, and the analysis is presented for a national audience focused on clinical, billing, and policy implications of using CPT code 0323U.

Billing Code Overview

CPT code 0323U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to the Johns Hopkins Metagenomic Next Generation Sequencing Assay for Infectious Disease Diagnostics, performed by Johns Hopkins Medical Microbiology Laboratory. The assay uses next-generation sequencing (NGS) of a cerebrospinal fluid (CSF) specimen to identify pathogenic organisms in patients with central nervous system infections of unknown origin.

Service type: Metagenomic next-generation sequencing diagnostic assay for infectious agents
Typical site of service: Clinical laboratory processing CSF specimens (hospital or reference laboratory setting)

Clinical Context

A patient presents with subacute meningitis characterized by fever, headache, neck stiffness, and altered mental status. Routine bacterial and viral CSF studies, Gram stain, culture, and targeted PCR panels are non-diagnostic, and the treating team is concerned for an uncommon or unexpected central nervous system (CNS) infection. A lumbar puncture is performed and cerebrospinal fluid (CSF) is sent to the Johns Hopkins Medical Microbiology Laboratory for the Johns Hopkins Metagenomic Next Generation Sequencing Assay for Infectious Disease Diagnostics. The assay performs unbiased metagenomic next-generation sequencing on CSF to detect bacterial, viral, fungal, or parasitic pathogens when standard testing is unrevealing.

The clinical workflow: the neurology or infectious disease team documents indications for advanced infectious testing for CNS infection of unknown origin, obtains informed consent as required, performs CSF collection via lumbar puncture in an appropriate setting (inpatient unit, emergency department, or outpatient infusion/clinic), labels and ships the specimen under required conditions to Johns Hopkins Medical Microbiology Laboratory, and orders reporting of results in the electronic health record. Results are used for pathogen identification to guide targeted therapy or infection control actions.

Coding Specifications

Modifier	Description	When to Use
`00`	Default single procedure indicator	Used by payors or systems requiring the default reporting flag for a single service

Taxonomy Code	Specialty	Notes
207RH0000X	Infectious Disease	Infectious disease physicians order and interpret advanced infectious diagnostics
2084P0800X	Neurology	Neurologists evaluate CNS infections and may order CSF testing
207K00000X	Pathology	Medical microbiology/pathology specialists oversee laboratory testing and result interpretation
208D00000X	Emergency Medicine	Emergency physicians may initiate testing when CSF obtained in ED
364S00000X	Clinical Laboratory	Clinical laboratory specialists perform testing and manage specimen workflow

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`G03.9`	Meningitis, unspecified	Common presenting syndrome prompting CSF metagenomic testing when etiology is unknown
`G04.90`	Encephalitis, unspecified, without coma	Encephalitis of unclear cause where CSF NGS may identify viral or other pathogens
`A87.9`	Viral meningitis, unspecified	Viral causes may be detected by metagenomic sequencing when standard panels are negative
`B25.9`	Cytomegaloviral disease, unspecified	Example of specific viral pathogens that may be identified by unbiased NGS
`G05.9`	Encephalitis, myelitis and encephalomyelitis, unspecified	CNS inflammatory syndromes of uncertain infectious etiology where broad pathogen testing is indicated
`A17.9`	Tuberculosis of nervous system, unspecified	Mycobacterial infections of the CNS can be detected by NGS when cultures are slow or negative
`B44.9`	Aspergillosis, unspecified	Fungal CNS infections may be identified by metagenomic assays when routine fungal tests are non-diagnostic

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`62270`	Spinal puncture, lumbar, diagnostic	Performed to obtain CSF specimen sent for the metagenomic NGS assay
`87077`	Culture, bacterial, other source, for aerobic and anaerobic organisms; with isolation and presumptive identification	May be performed in parallel for routine bacterial culture while awaiting NGS results
`87501`	Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; direct probe technique	Represents targeted molecular testing often performed before or concurrently with broad NGS assays
`88341`	Cytopathology, initial interpretation; CSF cytology	CSF cell differential and cytology often accompany infectious testing and inform interpretation
`99000`	Handling and/or conveyance of specimen	Ancillary code sometimes used for specimen handling logistics when supported by payor policy

OpenPayer

Summary & Overview